financetom
Business
financetom
/
Business
/
Solar services firm Spruce Power Q3 revenue jumps, helped by NJR acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Solar services firm Spruce Power Q3 revenue jumps, helped by NJR acquisition
Nov 11, 2025 1:57 PM

Overview

* Spruce Power ( SPRU ) Q3 revenue rises 44% yr/yr, driven by acquisitions and service agreements

* Net loss for Q3 narrows significantly compared to the previous year

* Operating EBITDA for Q3 increases 48% yr/yr, reflecting cost management

Outlook

* Spruce plans to decrease SG&A costs through workforce reduction and office closure

* Company engaged in discussions with financial institutions regarding 2026 debt obligations

Result Drivers

* REVENUE GROWTH - Revenue increased 44% yr/yr, driven by NJR acquisition and improved SRECs revenue

* COST REDUCTIONS - O&M expenses down 53% yr/yr due to meter upgrades and cost management

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $30.73

Revenue mln

Q3 EPS -$0.05

Q3 Net -$714,00

Income 0

Q3 $8.48

Income mln

From

Operatio

ns

Q3 Net -$677,00

Income 0

continui

ng

operatio

ns

Q3 $22.24

Operatin mln

g

Expenses

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Delaware judge says she will not block Metsera from ending Pfizer deal 
Delaware judge says she will not block Metsera from ending Pfizer deal 
Nov 5, 2025
WILMINGTON, Delaware, Nov 5 (Reuters) - A Delaware judge said on Wednesday she would reject a request by Pfizer ( PFE ) to temporarily block Metsera ( MTSR ) from terminating its takeover deal with Pfizer ( PFE ), allowing Metsera ( MTSR ) to proceed instead with a higher $10 billion deal from Novo Nordisk. ...
Lyft's slower-than-expected revenue growth clouds upbeat bookings forecast
Lyft's slower-than-expected revenue growth clouds upbeat bookings forecast
Nov 5, 2025
(Reuters) -Lyft ( LYFT ) reported third-quarter revenue growth a tad below Wall Street expectations on Wednesday amid intense competition in its core North American markets, overshadowing an upbeat bookings forecast for the holiday travel season. Shares of the San Francisco-based company fell about 3% in extended trading. The company has benefited from its recent push into international markets and...
Jazz Pharmaceuticals Q3 revenue beats estimates
Jazz Pharmaceuticals Q3 revenue beats estimates
Nov 5, 2025
Overview * Jazz Pharmaceuticals ( JAZZ ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting robust operational performance * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln Outlook * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln * Jazz Pharmaceuticals ( JAZZ ) expects top-line data from zanidatamab...
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens
Nov 5, 2025
Overview * Cytokinetics ( CYTK ) Q3 net loss widens to $306.2 mln, driven by debt conversion expense * Company reports Q3 revenue of $1.9 mln, up from $0.5 mln last year * Cytokinetics ( CYTK ) prepares for potential U.S. launch of aficamten pending FDA approval Outlook * Company expects EMA decision on aficamten MAA in 1H 2026 *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved